MRSA (n = 76) | MSSA (n = 179) | P-value | |
---|---|---|---|
Demographics | |||
Male | 34 (45) | 94 (53) | 0.2 |
Female | 42 (55) | 84 (47) | 0.2 |
Age (Years) | 3.5 [0.7–7.7] | 3.3 [0.9–11.2] | 0.4 |
Clinical characteristics | |||
Predisposing factor | 25 (33) | 67 (37) | 0.5 |
Chronic disease | 29 (38) | 66 (37) | 0.8 |
Recent antibiotic use | 29 (40) | 42 (25) | 0.01 |
Hospital-acquired | 20 (26) | 23 (13) | 0.02 |
Health care-associated | 17 (22) | 42 (23) | 0.8 |
Maximal CRP (mg/dl) | 3.6 [0.9–5.7] | 1.1 [0.2–5.9] | 0.045 |
Hospitalization days | 15 [8.5–21.5] | 10 [6–16.2] | 0.1 |
Site of infections | |||
SSTIs | 43 (57) | 104 (58) | 0.7 |
Bloodstream infections | 13 (17) | 22 (12) | 0.3 |
URTIs | 12 (16) | 36 (20) | 0.4 |
Acute conjunctivitis | 3 (4) | 7 (4) | 1 |
UTIs | 4 (5) | 2 (1) | 0.07 |
OAIs | 0 (0) | 5 (3) | 0.3 |
Others sites | 1 (1) | 3 (2) | 1 |